Frontlight ResearchEarly access
CompletedNo phase
Intrapartum Glucose Control and Risk of Neonatal Hypoglycemia
Key facts
- Who runs it
- University of Pittsburgh
- Where
- Pittsburgh, United StatesSee the site
- Trial code
- Status
- Completed
- People taking part
- 169 people enrolled
- Started
- 3 Dec 2024
- Ended
- 31 Jul 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Standard Intrapartum Glucose Target Range
- Liberalized Intrapartum Glucose Target Range
- Record updated
- 14 August 2026
Who can take part
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 6 criteriaShow less
Who can take part
- Pregnant patients with Pre-gestational (Type 1 or Type 2) or Gestational Diabetes
- Singleton Gestations
- Greater than or equal to 35 weeks gestation
- Planned for vaginal delivery at the University of Pittsburgh Medical Center Magee-Womens Hospital (UPMC MWH)
Who cannot take part
- Major fetal anomalies anticipated to require NICU admission
- Planned Cesarean delivery
Where in United States
- Magee Women's Hospital of UPMCPittsburgh, United States
About the trial
What the trial wants to find out
The purpose of this study is to assess whether a liberal intrapartum glycemic target range compared to usual care standard control ranges will lead to a decrease in the rate of neonatal hypoglycemia among pregnant patients in labor with diabetes.
The 2 groups in the trial
- Standard Intrapartum Glucose Target RangeExisting treatment, for comparison
The goal intrapartum glucose target range will be 70-110mg/dl. Insulin infusion will be initiated when maternal capillary glucose exceeds 110 mg/dL.
- Liberalized Intrapartum Glucose Target RangeTreatment being tested
The goal intrapartum glucose target range will be 70-160mg/dl. Insulin infusion will be initiated when maternal capillary glucose exceeds 160 mg/dL.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Intrapartum Maternal Glucose Control and Effect on Neonatal Hypoglycemia
- Record updated
- 14 August 2026